AU2002210761A1 - Method of determining susceptibility to diseases - Google Patents
Method of determining susceptibility to diseasesInfo
- Publication number
- AU2002210761A1 AU2002210761A1 AU2002210761A AU1076102A AU2002210761A1 AU 2002210761 A1 AU2002210761 A1 AU 2002210761A1 AU 2002210761 A AU2002210761 A AU 2002210761A AU 1076102 A AU1076102 A AU 1076102A AU 2002210761 A1 AU2002210761 A1 AU 2002210761A1
- Authority
- AU
- Australia
- Prior art keywords
- diseases
- determining susceptibility
- susceptibility
- determining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Physics & Mathematics (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0026945A GB0026945D0 (en) | 2000-11-03 | 2000-11-03 | Therapy |
| GB0026945.6 | 2000-11-03 | ||
| GB0029577.4 | 2000-12-02 | ||
| GB0029577A GB0029577D0 (en) | 2000-12-02 | 2000-12-02 | Therapy |
| PCT/GB2001/004865 WO2002036816A2 (en) | 2000-11-03 | 2001-11-02 | Method of determining susceptibility to diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002210761A1 true AU2002210761A1 (en) | 2002-05-15 |
Family
ID=26245235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002210761A Abandoned AU2002210761A1 (en) | 2000-11-03 | 2001-11-02 | Method of determining susceptibility to diseases |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002210761A1 (en) |
| WO (1) | WO2002036816A2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20060272A1 (en) | 2004-05-24 | 2006-05-22 | Glaxo Group Ltd | (2R, 3R, 4S, 5R, 2'R, 3'R, 4'S, 5'S) -2.2 '- {TRANS-1,4-CYCLOHEXANODIYLBIS- [IMINO (2 - {[2- (1-METHYL- 1H-IMIDAZOL-4-IL) ETHYL] AMINO} -9H-PURIN-6,9-DIYL)]} BIS [5- (2-ETHYL-2H-TETRAZOLE-5-IL) TETRAHYDRO-3,4-FURANODIOL] AS AN A2A AGONIST |
| SE0402832D0 (en) * | 2004-11-18 | 2004-11-18 | Astrazeneca Ab | Methods |
| GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
-
2001
- 2001-11-02 WO PCT/GB2001/004865 patent/WO2002036816A2/en not_active Ceased
- 2001-11-02 AU AU2002210761A patent/AU2002210761A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002036816A3 (en) | 2003-05-30 |
| WO2002036816A2 (en) | 2002-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL153824A0 (en) | Method and kit for diagnosis of diseases | |
| AU2002243231A1 (en) | Method of treating autoimmune diseases | |
| AU2002220920A1 (en) | Method for identification of genes involved in specific diseases | |
| AU2001234608A1 (en) | Methods for analysis of gene expression | |
| AU2002332430A1 (en) | Methods of treating neuropilin-mediated diseases | |
| AU2002228991A1 (en) | Methods for treating diseases caused by deficiencies of alpha-l-iduronidase | |
| SG94782A1 (en) | Method for production of acrylic acid | |
| AU2002214286A1 (en) | Method of profiling protein | |
| AU2001267428A1 (en) | Direct detection of individual molecules | |
| AU2001277815A1 (en) | Method to determine the quality of eye-optics | |
| AU2001294258A1 (en) | Method of purifying plavastatin | |
| AU2002330624A1 (en) | Method of determining susceptibility to inflammatory bowel disease | |
| AU2001280436A1 (en) | Process to increase protein stability | |
| AU2002301109A1 (en) | Method for the prediction of preeclampsia and other diseases | |
| GB2360646B (en) | Method of displaying full-charge-state | |
| AU2002210761A1 (en) | Method of determining susceptibility to diseases | |
| AU2002246926A1 (en) | 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof | |
| NO20031927L (en) | Improved process for preparation of gabapentin intermediate | |
| AU2001273392A1 (en) | Method of detecting an increased susceptibility to breast cancer | |
| AU2001258659A1 (en) | Improved methods of transfection | |
| AU2001292468A1 (en) | Methods and means of rna analysis | |
| AU2001232571A1 (en) | Method relating to manufacturing of steel | |
| AU2002237238A1 (en) | Identification of modulators of dham-kinase and inflammatory diseases | |
| GB0100151D0 (en) | Methods of sputtering | |
| AU2001233246A1 (en) | Novel use of ribozymes to block gene expression |